Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Sealed Air NYSE SEE Exceeds Analyst Expectations in Quarterly Earnings Despite YearOverYear Decrease

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Sealed Air (NYSE: SEE) announced their quarterly earnings on February 27, 2024, with a profit of $0.88 per share. This exceeded the expectations of analysts by 37.5%. However, this figure is down 11.11% from the previous year’s earnings of $0.99 per share.

The company also reported quarterly sales of $1.38 billion, slightly higher than the analyst consensus estimate of $1.37 billion by 0.58%. Despite this, there was a 1.99% decrease in sales compared to the same period last year when sales reached $1.41 billion.

Sealed Air Corporation (SEE) Stock Price Faces Volatility and Uncertainty

On February 27, 2024, Sealed Air Corporation (SEE) experienced a slight decrease in its stock price. According to data from CNN Money, SEE is currently trading in the middle of its 52-week range and below its 200-day simple moving average. This indicates that the stock may be experiencing some volatility and uncertainty in the market.

The price of SEE shares decreased by $0.50 since the market last closed, representing a 1.37% drop. The stock closed at $36.08 on the previous trading day. However, there was a slight uptick in pre-market trading, with the stock rising by $0.42.

While the pre-market increase may indicate some positive momentum for SEE, investors should remain cautious as the stock is still trading below its 200-day moving average. This suggests that the stock may continue to face resistance and struggle to maintain its upward momentum in the short term.

SEE Stock Performance Analysis: Stable Revenue but Decline in Net Income Raises Concerns for Investors

On February 27, 2024, investors closely monitored the stock performance of SEE, a company that specializes in packaging solutions. The company’s financial data, sourced from CNN Money, revealed that SEE’s total revenue for the past year was $5.64 billion, with a quarterly revenue of $1.38 billion. Interestingly, both figures remained flat compared to the previous year and quarter, indicating a stable performance in terms of revenue generation.

However, when it comes to net income, SEE reported a total of $491.30 million for the past year, with a quarterly net income of $57.60 million. While the net income remained flat compared to the previous year, it decreased by 38.66% since the last quarter. This decline in net income could be a cause for concern for investors, as it suggests a potential slowdown in profitability for the company.

In terms of earnings per share (EPS), SEE reported $3.33 for the past year and $0.40 for the last quarter. The EPS increased by 3.41% since the previous year but decreased by 38.7% since the last quarter. This decrease in EPS could be attributed to the decline in net income, as lower profitability can impact the earnings distributed to shareholders.

Overall, SEE’s stock performance on February 27, 2024, reflected a mixed bag of results. While the company maintained stable revenue figures, the decline in net income and EPS could raise concerns among investors. It will be interesting to see how SEE addresses these challenges and whether they can bounce back in the coming quarters to regain investor confidence. Investors should keep a close eye on SEE’s financial performance and strategic decisions to make informed investment decisions.

Tags: SEE
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Renewable-energy

Delek US Holdings Reports Quarterly Loss and Strategic Initiatives for Future Growth

Apellis Pharmaceuticals Reports Quarterly Loss and Revenue Growth in Q4 2023

Ligand Pharmaceuticals Reports Strong Fourth Quarter Earnings and Sales Performance

Recommended

Warner Bros. Discovery (A) Stock

Acquisition Battle Intensifies for Warner Bros. Discovery

3 months ago
Reviva Pharmaceuticals Holdings Stock

Reviva Pharmaceuticals Stock Surges on Extraordinary Trading Activity

4 months ago
MMM stock news

Analyst Insights and Price Targets for BILL Holdings

2 years ago
IonQ Stock

IonQ Shares Experience Technical Breakthrough Amid Market Correction

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

DroneShield Shares Face Headwinds Despite Record Performance

Rock Tech Lithium: Investors Await the Final Go-Ahead

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Trending

Chicago Atlantic Real Estate Finance Stock
Analysis

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

by SiterGedge
February 8, 2026
0

Investors in Chicago Atlantic Real Estate Finance have received welcome clarification regarding the tax treatment of the...

RBB Stock

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

February 8, 2026
Cassava Sciences Stock

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

February 8, 2026
DroneShield Stock

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026
Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic
  • RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review
  • Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com